Industry Research Reports

Home > Reports > Service & Software > Virus-like Particles (VLPs) Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Virus-like Particles (VLPs) Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-12

Pages: 99 Pages

Report ld: 4650054

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose their original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.

North American market for Virus-like Particles (VLPs) Delivery System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Virus-like Particles (VLPs) Delivery System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Virus-like Particles (VLPs) Delivery System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Virus-like Particles (VLPs) Delivery System include WuXi Biologics, Creative Biolabs, Creative Biogene, Creative Biostructure, Cusabio Technology LLC, Creative Diagnostics, ARTES Biotechnology GmbH, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Virus-like Particles (VLPs) Delivery System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Virus-like Particles (VLPs) Delivery System by region & country, by Type, and by Application.

The Virus-like Particles (VLPs) Delivery System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virus-like Particles (VLPs) Delivery System.

MARKET SEGMENTATION

By Company

WuXi Biologics
Creative Biolabs
Creative Biogene
Creative Biostructure
Cusabio Technology LLC
Creative Diagnostics
ARTES Biotechnology GmbH

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Insect Cell System
Mammalian Cell System
Plant System
Yeast System
E. coli System

Segment by Application

DNA
RNA
Peptide
Protein
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Virus-like Particles (VLPs) Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Virus-like Particles (VLPs) Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Virus-like Particles (VLPs) Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Virus-like Particles (VLPs) Delivery System Product Introduction

1.2 Global Virus-like Particles (VLPs) Delivery System Market Size Forecast (2020-2031)

1.3 Virus-like Particles (VLPs) Delivery System Market Trends & Drivers

1.3.1 Virus-like Particles (VLPs) Delivery System Industry Trends

1.3.2 Virus-like Particles (VLPs) Delivery System Market Drivers & Opportunity

1.3.3 Virus-like Particles (VLPs) Delivery System Market Challenges

1.3.4 Virus-like Particles (VLPs) Delivery System Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Virus-like Particles (VLPs) Delivery System Players Revenue Ranking (2024)

2.2 Global Virus-like Particles (VLPs) Delivery System Revenue by Company (2020-2025)

2.3 Key Companies Virus-like Particles (VLPs) Delivery System Manufacturing Base Distribution and Headquarters

2.4 Key Companies Virus-like Particles (VLPs) Delivery System Product Offered

2.5 Key Companies Time to Begin Mass Production of Virus-like Particles (VLPs) Delivery System

2.6 Virus-like Particles (VLPs) Delivery System Market Competitive Analysis

2.6.1 Virus-like Particles (VLPs) Delivery System Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Virus-like Particles (VLPs) Delivery System Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particles (VLPs) Delivery System as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Insect Cell System

3.1.2 Mammalian Cell System

3.1.3 Plant System

3.1.4 Yeast System

3.1.5 E. coli System

3.2 Global Virus-like Particles (VLPs) Delivery System Sales Value by Type

3.2.1 Global Virus-like Particles (VLPs) Delivery System Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Virus-like Particles (VLPs) Delivery System Sales Value, by Type (2020-2031)

3.2.3 Global Virus-like Particles (VLPs) Delivery System Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 DNA

4.1.2 RNA

4.1.3 Peptide

4.1.4 Protein

4.1.5 Other

4.2 Global Virus-like Particles (VLPs) Delivery System Sales Value by Application

4.2.1 Global Virus-like Particles (VLPs) Delivery System Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Virus-like Particles (VLPs) Delivery System Sales Value, by Application (2020-2031)

4.2.3 Global Virus-like Particles (VLPs) Delivery System Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Virus-like Particles (VLPs) Delivery System Sales Value by Region

5.1.1 Global Virus-like Particles (VLPs) Delivery System Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (2020-2025)

5.1.3 Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (2026-2031)

5.1.4 Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

5.2.2 North America Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

5.3.2 Europe Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

5.4.2 Asia Pacific Virus-like Particles (VLPs) Delivery System Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

5.5.2 South America Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

5.6.2 Middle East & Africa Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Virus-like Particles (VLPs) Delivery System Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.3 United States

6.3.1 United States Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.3.2 United States Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.4.2 Europe Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.5.2 China Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.5.3 China Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.6.2 Japan Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.7.2 South Korea Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.8.2 Southeast Asia Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Virus-like Particles (VLPs) Delivery System Sales Value, 2020-2031

6.9.2 India Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

6.9.3 India Virus-like Particles (VLPs) Delivery System Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 WuXi Biologics

7.1.1 WuXi Biologics Profile

7.1.2 WuXi Biologics Main Business

7.1.3 WuXi Biologics Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.1.4 WuXi Biologics Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.1.5 WuXi Biologics Recent Developments

7.2 Creative Biolabs

7.2.1 Creative Biolabs Profile

7.2.2 Creative Biolabs Main Business

7.2.3 Creative Biolabs Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.2.4 Creative Biolabs Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.2.5 Creative Biolabs Recent Developments

7.3 Creative Biogene

7.3.1 Creative Biogene Profile

7.3.2 Creative Biogene Main Business

7.3.3 Creative Biogene Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.3.4 Creative Biogene Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.3.5 Creative Biogene Recent Developments

7.4 Creative Biostructure

7.4.1 Creative Biostructure Profile

7.4.2 Creative Biostructure Main Business

7.4.3 Creative Biostructure Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.4.4 Creative Biostructure Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.4.5 Creative Biostructure Recent Developments

7.5 Cusabio Technology LLC

7.5.1 Cusabio Technology LLC Profile

7.5.2 Cusabio Technology LLC Main Business

7.5.3 Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.5.4 Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.5.5 Cusabio Technology LLC Recent Developments

7.6 Creative Diagnostics

7.6.1 Creative Diagnostics Profile

7.6.2 Creative Diagnostics Main Business

7.6.3 Creative Diagnostics Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.6.4 Creative Diagnostics Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.6.5 Creative Diagnostics Recent Developments

7.7 ARTES Biotechnology GmbH

7.7.1 ARTES Biotechnology GmbH Profile

7.7.2 ARTES Biotechnology GmbH Main Business

7.7.3 ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

7.7.4 ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Revenue (US$ Million) & (2020-2025)

7.7.5 ARTES Biotechnology GmbH Recent Developments

8 Industry Chain Analysis

8.1 Virus-like Particles (VLPs) Delivery System Industrial Chain

8.2 Virus-like Particles (VLPs) Delivery System Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Virus-like Particles (VLPs) Delivery System Sales Model

8.5.2 Sales Channel

8.5.3 Virus-like Particles (VLPs) Delivery System Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Virus-like Particles (VLPs) Delivery System Market Trends

Table 2. Virus-like Particles (VLPs) Delivery System Market Drivers & Opportunity

Table 3. Virus-like Particles (VLPs) Delivery System Market Challenges

Table 4. Virus-like Particles (VLPs) Delivery System Market Restraints

Table 5. Global Virus-like Particles (VLPs) Delivery System Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Virus-like Particles (VLPs) Delivery System Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Virus-like Particles (VLPs) Delivery System Product Type

Table 9. Key Companies Time to Begin Mass Production of Virus-like Particles (VLPs) Delivery System

Table 10. Global Virus-like Particles (VLPs) Delivery System Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particles (VLPs) Delivery System as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Virus-like Particles (VLPs) Delivery System Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Virus-like Particles (VLPs) Delivery System Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Virus-like Particles (VLPs) Delivery System Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Virus-like Particles (VLPs) Delivery System Sales Market Share in Value by Type (2020-2025)

Table 17. Global Virus-like Particles (VLPs) Delivery System Sales Market Share in Value by Type (2026-2031)

Table 18. Global Virus-like Particles (VLPs) Delivery System Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Virus-like Particles (VLPs) Delivery System Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Virus-like Particles (VLPs) Delivery System Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Virus-like Particles (VLPs) Delivery System Sales Market Share in Value by Application (2020-2025)

Table 22. Global Virus-like Particles (VLPs) Delivery System Sales Market Share in Value by Application (2026-2031)

Table 23. Global Virus-like Particles (VLPs) Delivery System Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (2020-2025) & (%)

Table 27. Global Virus-like Particles (VLPs) Delivery System Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Virus-like Particles (VLPs) Delivery System Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Virus-like Particles (VLPs) Delivery System Sales Value, (2026-2031) & (US$ Million)

Table 31. WuXi Biologics Basic Information List

Table 32. WuXi Biologics Description and Business Overview

Table 33. WuXi Biologics Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 34. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of WuXi Biologics (2020-2025)

Table 35. WuXi Biologics Recent Developments

Table 36. Creative Biolabs Basic Information List

Table 37. Creative Biolabs Description and Business Overview

Table 38. Creative Biolabs Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 39. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of Creative Biolabs (2020-2025)

Table 40. Creative Biolabs Recent Developments

Table 41. Creative Biogene Basic Information List

Table 42. Creative Biogene Description and Business Overview

Table 43. Creative Biogene Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 44. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of Creative Biogene (2020-2025)

Table 45. Creative Biogene Recent Developments

Table 46. Creative Biostructure Basic Information List

Table 47. Creative Biostructure Description and Business Overview

Table 48. Creative Biostructure Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 49. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of Creative Biostructure (2020-2025)

Table 50. Creative Biostructure Recent Developments

Table 51. Cusabio Technology LLC Basic Information List

Table 52. Cusabio Technology LLC Description and Business Overview

Table 53. Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 54. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of Cusabio Technology LLC (2020-2025)

Table 55. Cusabio Technology LLC Recent Developments

Table 56. Creative Diagnostics Basic Information List

Table 57. Creative Diagnostics Description and Business Overview

Table 58. Creative Diagnostics Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 59. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of Creative Diagnostics (2020-2025)

Table 60. Creative Diagnostics Recent Developments

Table 61. ARTES Biotechnology GmbH Basic Information List

Table 62. ARTES Biotechnology GmbH Description and Business Overview

Table 63. ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Products, Services and Solutions

Table 64. Revenue (US$ Million) in Virus-like Particles (VLPs) Delivery System Business of ARTES Biotechnology GmbH (2020-2025)

Table 65. ARTES Biotechnology GmbH Recent Developments

Table 66. Key Raw Materials Lists

Table 67. Raw Materials Key Suppliers Lists

Table 68. Virus-like Particles (VLPs) Delivery System Downstream Customers

Table 69. Virus-like Particles (VLPs) Delivery System Distributors List

Table 70. Research Programs/Design for This Report

Table 71. Key Data Information from Secondary Sources

Table 72. Key Data Information from Primary Sources

List of Figures

Figure 1. Virus-like Particles (VLPs) Delivery System Product Picture

Figure 2. Global Virus-like Particles (VLPs) Delivery System Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Virus-like Particles (VLPs) Delivery System Sales Value (2020-2031) & (US$ Million)

Figure 4. Virus-like Particles (VLPs) Delivery System Report Years Considered

Figure 5. Global Virus-like Particles (VLPs) Delivery System Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Virus-like Particles (VLPs) Delivery System Revenue in 2024

Figure 7. Virus-like Particles (VLPs) Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Insect Cell System Picture

Figure 9. Mammalian Cell System Picture

Figure 10. Plant System Picture

Figure 11. Yeast System Picture

Figure 12. E. coli System Picture

Figure 13. Global Virus-like Particles (VLPs) Delivery System Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Virus-like Particles (VLPs) Delivery System Sales Value Market Share by Type, 2024 & 2031

Figure 15. Product Picture of DNA

Figure 16. Product Picture of RNA

Figure 17. Product Picture of Peptide

Figure 18. Product Picture of Protein

Figure 19. Product Picture of Other

Figure 20. Global Virus-like Particles (VLPs) Delivery System Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Virus-like Particles (VLPs) Delivery System Sales Value Market Share by Application, 2024 & 2031

Figure 22. North America Virus-like Particles (VLPs) Delivery System Sales Value (2020-2031) & (US$ Million)

Figure 23. North America Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 24. Europe Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 25. Europe Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 26. Asia Pacific Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 27. Asia Pacific Virus-like Particles (VLPs) Delivery System Sales Value by Region (%), 2024 VS 2031

Figure 28. South America Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 29. South America Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 30. Middle East & Africa Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 31. Middle East & Africa Virus-like Particles (VLPs) Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 32. Key Countries/Regions Virus-like Particles (VLPs) Delivery System Sales Value (%), (2020-2031)

Figure 33. United States Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 34. United States Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 35. United States Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 36. Europe Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 37. Europe Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 38. Europe Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 39. China Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 40. China Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 41. China Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 42. Japan Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 43. Japan Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 44. Japan Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 45. South Korea Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 46. South Korea Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 47. South Korea Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 48. Southeast Asia Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 49. Southeast Asia Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 50. Southeast Asia Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 51. India Virus-like Particles (VLPs) Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 52. India Virus-like Particles (VLPs) Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 53. India Virus-like Particles (VLPs) Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 54. Virus-like Particles (VLPs) Delivery System Industrial Chain

Figure 55. Virus-like Particles (VLPs) Delivery System Manufacturing Cost Structure

Figure 56. Channels of Distribution (Direct Sales, and Distribution)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Virus-like Particles (VLPs) Delivery System market? zhanKai

The top companies in the global Virus-like Particles (VLPs) Delivery System market are WuXi Biologics、Creative Biolabs、Creative Biogene.

Related Reports

Global Virus-like Particles (VLPs) Delivery System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 120
USD 4900.00
(Single User License)
Global Virus-like Particles (VLPs) Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 79
USD 4250.00
(Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Research Report 2026
The global Virus-like Particles (VLPs) Delivery System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 107
USD 2900.00
(Single User License)
Virus-like Particles (VLPs) Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 94
USD 3950.00
(Single User License)
Global Virus-like Particles (VLPs) Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 121
USD 4900.00
(Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Research Report 2025
The global market for Virus-like Particles (VLPs) Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 71
USD 2900.00
(Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Insights, Forecast to 2030
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-11-12
Pages: 129
USD 4900.00
(Single User License)
Global and United States Virus-like Particles (VLPs) Delivery System Market Report & Forecast 2024-2030
The global Virus-like Particles (VLPs) Delivery System revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-11-12
Pages: 93
USD 4350.00
(Single User License)
Virus-like Particles (VLPs) Delivery System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-11-12
Pages: 91
USD 3950.00
(Single User License)

Global Virus-like Particles (VLPs) Delivery System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 120
USD 4900.00 (Single User License)
Global Virus-like Particles (VLPs) Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 79
USD 4250.00 (Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Research Report 2026
The global Virus-like Particles (VLPs) Delivery System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 107
USD 2900.00 (Single User License)
Virus-like Particles (VLPs) Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 94
USD 3950.00 (Single User License)
Global Virus-like Particles (VLPs) Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
USD 4250.00 (Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 121
USD 4900.00 (Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Research Report 2025
The global market for Virus-like Particles (VLPs) Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 71
USD 2900.00 (Single User License)
Global Virus-like Particles (VLPs) Delivery System Market Insights, Forecast to 2030
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-11-12
Pages: 129
USD 4900.00 (Single User License)
Global and United States Virus-like Particles (VLPs) Delivery System Market Report & Forecast 2024-2030
The global Virus-like Particles (VLPs) Delivery System revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-11-12
Pages: 93
USD 4350.00 (Single User License)
Virus-like Particles (VLPs) Delivery System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-11-12
Pages: 91
USD 3950.00 (Single User License)